Kopran Limited

NSE KOPRAN.NS

Kopran Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 118.51 K

Kopran Limited Net Cash Used Provided By Financing Activities is USD 118.51 K for the year ending March 31, 2024, a 104.91% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Kopran Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD -2.41 M, a -114.93% change year over year.
Kopran Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 16.18 M, a 442.61% change year over year.
Kopran Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -4.72 M, a -96.95% change year over year.
Kopran Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -2.40 M, a -2,766.27% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

NSE: KOPRAN.NS

Kopran Limited

CEO	Mr. Surendra Shrikrishna Somani B.Com.
IPO Date	July 1, 2002
Location	India
Headquarters	Parijat House
Employees	842
Sector	Health Care
Industries Pharmaceuticals

Description

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.

Key trends

Past 5 years